163 related articles for article (PubMed ID: 9006320)
21. The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord.
Geist RT; Gutmann DH
Cell Growth Differ; 1995 Nov; 6(11):1477-83. PubMed ID: 8562486
[TBL] [Abstract][Full Text] [Related]
22. Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues.
Xu L; Sterner C; Maheshwar MM; Wilson PJ; Nellist M; Short PM; Haines JL; Sampson JR; Ramesh V
Genomics; 1995 Jun; 27(3):475-80. PubMed ID: 7558029
[TBL] [Abstract][Full Text] [Related]
23. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression.
Soucek T; Rosner M; Miloloza A; Kubista M; Cheadle JP; Sampson JR; Hengstschläger M
Oncogene; 2001 Aug; 20(35):4904-9. PubMed ID: 11521203
[TBL] [Abstract][Full Text] [Related]
24. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.
Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
Biochem Biophys Res Commun; 2003 Dec; 312(3):676-83. PubMed ID: 14680818
[TBL] [Abstract][Full Text] [Related]
25. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis.
Wenzel HJ; Patel LS; Robbins CA; Emmi A; Yeung RS; Schwartzkroin PA
Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103
[TBL] [Abstract][Full Text] [Related]
26. Ezrin and moesin expression within the developing human cerebrum and tuberous sclerosis-associated cortical tubers.
Johnson MW; Miyata H; Vinters HV
Acta Neuropathol; 2002 Aug; 104(2):188-96. PubMed ID: 12111362
[TBL] [Abstract][Full Text] [Related]
27. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity.
Wienecke R; König A; DeClue JE
J Biol Chem; 1995 Jul; 270(27):16409-14. PubMed ID: 7608212
[TBL] [Abstract][Full Text] [Related]
28. The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach.
Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
Int J Oncol; 2005 Sep; 27(3):831-8. PubMed ID: 16077935
[TBL] [Abstract][Full Text] [Related]
29. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.
Maheshwar MM; Cheadle JP; Jones AC; Myring J; Fryer AE; Harris PC; Sampson JR
Hum Mol Genet; 1997 Oct; 6(11):1991-6. PubMed ID: 9302281
[TBL] [Abstract][Full Text] [Related]
30. Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer.
Kataoka K; Fujimoto K; Ito D; Koizumi M; Toyoda E; Mori T; Kami K; Doi R
Surgery; 2005 Sep; 138(3):450-5. PubMed ID: 16213898
[TBL] [Abstract][Full Text] [Related]
31. A calmodulin binding site in the tuberous sclerosis 2 gene product is essential for regulation of transcription events and is altered by mutations linked to tuberous sclerosis and lymphangioleiomyomatosis.
Noonan DJ; Lou D; Griffith N; Vanaman TC
Arch Biochem Biophys; 2002 Feb; 398(1):132-40. PubMed ID: 11811958
[TBL] [Abstract][Full Text] [Related]
32. HMB-45 and tuberin in hamartomas associated with tuberous sclerosis.
Kimura N; Watanabe M; Date F; Kitamoto T; Kumura I; Horii A; Nagura H
Mod Pathol; 1997 Sep; 10(9):952-9. PubMed ID: 9310961
[TBL] [Abstract][Full Text] [Related]
33. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice.
Kobayashi T; Minowa O; Kuno J; Mitani H; Hino O; Noda T
Cancer Res; 1999 Mar; 59(6):1206-11. PubMed ID: 10096549
[TBL] [Abstract][Full Text] [Related]
34. Antisense suppression of TSC1 gene product, hamartin, enhances neurite outgrowth in NGF-treated PC12h cells.
Floricel F; Higaki K; Maki H; Nanba E; Ninomiya H; Ohno K
Brain Dev; 2007 Sep; 29(8):502-9. PubMed ID: 17376623
[TBL] [Abstract][Full Text] [Related]
35. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.
Benvenuto G; Li S; Brown SJ; Braverman R; Vass WC; Cheadle JP; Halley DJ; Sampson JR; Wienecke R; DeClue JE
Oncogene; 2000 Dec; 19(54):6306-16. PubMed ID: 11175345
[TBL] [Abstract][Full Text] [Related]
36. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.
Tsuchiya H; Orimoto K; Kobayashi K; Hino O
Cancer Res; 1996 Feb; 56(3):429-33. PubMed ID: 8564946
[TBL] [Abstract][Full Text] [Related]
37. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.
Jin F; Wienecke R; Xiao GH; Maize JC; DeClue JE; Yeung RS
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9154-9. PubMed ID: 8799170
[TBL] [Abstract][Full Text] [Related]
38. Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex.
Ali M; Girimaji SC; Markandaya M; Shukla AK; Sacchidanand S; Kumar A
Acta Neurol Scand; 2005 Jan; 111(1):54-63. PubMed ID: 15595939
[TBL] [Abstract][Full Text] [Related]
39. Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas.
Wienecke R; Klemm E; Karparti S; Swanson NA; Green AJ; DeClue JE
J Cutan Pathol; 2002 May; 29(5):287-90. PubMed ID: 12100629
[TBL] [Abstract][Full Text] [Related]
40. Alterations in the rap1 signaling pathway are common in human gliomas.
Gutmann DH; Saporito-Irwin S; DeClue JE; Wienecke R; Guha A
Oncogene; 1997 Sep; 15(13):1611-6. PubMed ID: 9380414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
